Clinical Report: Cervical Cancer Screening Patterns Across Race and Ethnicity, Age, Language, and US Census Region

Overview

This retrospective cross-sectional study examined cervical cancer screening (CCS) patterns from 2019 through 2024 across race and ethnicity, age, language, and US Census region using deidentified aggregate data from Epic Cosmos. The supplied article context describes the study rationale and methods but does not provide its results; therefore, subgroup trends or differences cannot be reported here.

Background

Cervical cancer causes approximately 13,000 new diagnoses and 4,000 deaths annually in the United States, although routine screening can prevent much of the disease and treatment is often successful when abnormalities are detected early. In 2023, 51.6% of women aged 25 to 44 years and 75.8% of all eligible women reported being up to date with screening, below the Healthy People 2030 goal of 84.3%. Prior research described differences in screening by race and ethnicity, age, rurality, and English proficiency, while the COVID-19 pandemic was associated with substantial reductions in screening. The study was designed to assess longitudinal patterns across multiple demographic and geographic groups before, during, and after the pandemic.

Data Highlights

Key Findings

• The study evaluated CCS patterns from 2019 through 2024, including the COVID-19 pandemic period.
• Screening patterns were examined by race and ethnicity, age, language, and US Census region.
• The analysis used preaggregated, deidentified summary data derived from patient-level electronic medical records in Epic Cosmos.
• The database included records from patients in all 50 US states and Washington, DC, as well as Canada, Lebanon, and Saudi Arabia; international records accounted for 0.15% of records, according to the supplied context.
• The supplied context reports that 2023 screening rates were 51.6% among women aged 25 to 44 years and 75.8% among all eligible women, compared with the Healthy People 2030 goal of 84.3%.
• A related 2022 ASCO meeting abstract is identified as addressing racial and ethnic disparities in the cervical cancer screening cascade across three US health care settings; no findings from that abstract are provided in the supplied material.

Clinical Implications

The supplied material establishes that screening uptake has been below the Healthy People 2030 goal and that prior research has identified disparities across population groups. Because the study's subgroup results are not included in the provided context, it does not support specific conclusions about which groups had higher or lower screening rates during 2019–2024.

Conclusion

The study was designed to characterize CCS patterns across demographic and geographic groups over a six-year period that included the COVID-19 pandemic. Its results are not available in the supplied material, limiting conclusions about observed trends or disparities.

Related Resources & Content

1. JAMA Network Open, 2026 -- Cervical Cancer Screening Rates by Race and Ethnicity, Age, Language, and Census Region
2. ASCO Quality Care Symposium, 2022 -- Racial and ethnic disparities in the cervical cancer screening cascade in three U.S. health care settings
3. Centers for Disease Control and Prevention, 2025 -- Use of Cancer Screening Tests, United States, 2023
4. ASCO Publications — Racial and ethnic disparities in the cervical cancer screening cascade in three U.S. health care settings.
5. ASCO Publications — Racial and ethnic disparities in the cervical cancer screening cascade in three U.S. health care settings.
6. ASCO Publications — Retrospective study of guideline concordance in cervical cancer screening surveillance by age, race, and ethnicity.
7. Cervical Cancer Screening Rates by Race and Ethnicity, Age, Language, and Census Region
8. Racial and ethnic disparities in the cervical cancer screening cascade in three U.S. health care settings
9. 286 Federal Register / Vol. 91, No. 2 / Monday, January 5, 2026 / Notices
10. cobas HPV Test for 4800 System – P100020/S055 | FDA
11. Cervical Cancer Screening Rates by Race and Ethnicity, Age, Language, and Census Region | Public Health | JAMA Network Open | JAMA Network